HIV Ag/Ab | Back to Test Directory | ||||
Test Description |
|
||||
Screening test for the qualitative detection of HIV p24 antigen and antibodies to HIV-1 (Groups M and O) and HIV-2. Positive test results will be confirmed with a supplemental differentiation test. | |||||
Reflex Test(s) | |||||
HIV-1/2 Antibody Differentiation Supplemental by Qualitative Enzyme Immunoassay (EIA) | |||||
Performed | Avg. Turnaround Time | Method | |||
Coralville, 8 a.m. - 5 p.m., M-F |
2 - 3 business days | Chemiluminescent Immunoassay (CLIA) - DiaSorin | |||
Fee | CPT Code(s) | ||||
$31.56 | 87389 | ||||
Specimen Requirements | |||||
Specimen Type: | Minimum 1 mL Serum | ||||
Collection Instructions: |
Red Top Tube:centrifuge and transfer serum to a secondary tube |
||||
Temperature and Stability: | Refrigerated (2-8°C); stable for 2 weeks. | ||||
Unacceptable Conditions: | Plasma, CSF. Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens. | ||||
Expected Results: | Non Reactive, Reactive | ||||
Shipping Instructions | |||||
Wrap specimen container in absorbent material and place inside a biohazard bag. Transport specimen with cold pack. Ship to the Coralville location. | |||||
Comments | |||||
A Reactive result indicates presence of HIV p24 antigen and/or HIV specific antibodies and a supplemental test will follow (HIV-1/2 Antibody Differentiation Supplemental by Qualitative Enzyme Immunoassay (EIA)). A Nonreactive result indicates no HIV p24 antigen or HIV specific antibodies present. Tests of Public Health Significance (TOPHS): All tests submitted to SHL at no charge as Tests of Public Health Significance (TOPHS) must come from State of Iowa Department of Health and Human Services (HHS)-approved test sites, such as Community-Based Screening Services (CBSS) and Integrated Testing Services (ITS) sites. To qualify as TOPHS testing individuals must must meet one or more of the following criteria: 1. Men who have sex with men; 2. Disproportionately impacted populations (as determined by Iowa HHS based on epidemiological data) -- Black/African American, Hispanic/Latino; 3. Persons who have ever injected drugs (PWID); 4. Persons who exchange sex for drugs or money; 5. Persons with an STI diagnosis within the last 12 months or someone who has a partner in another risk group (PWID, MSM, recent STI, exchange sex for drugs or money); or 6. Persons in need of confirmatory testing who have had reactive rapid HIV test results at an Iowa HHS-approved site -- select "Previous related diagnosis/therapy" as an indicated risk. | |||||
Alternate Names | |||||
HIV-1/HIV-2 Discriminatory Assay, HIV-1/2 Ag/Ab Combo, Multispot HIV-1/HIV-2 Rapid Test |